This summer, at least 16 individuals have succumbed to heatstroke in southern India as temperatures continue to rise, prompting health warnings from officials.
A recent doctoral thesis from the University of Gothenburg suggests that fluctuations in work capacity may serve as early indicators of potential sick leave, paving the way for better employee support.
Green chemistry presents a transformative approach to resource usage, aiming to minimize waste and harmful substances while balancing benefits with environmental health.
With Congress reducing Medicaid funding for healthcare providers, the Trump administration is pushing for further cuts, leaving hospitals to prepare for the financial ramifications on patient care.
As natural disasters become more frequent, the pressure on disaster responders intensifies, potentially compromising their health and effectiveness due to unclear tasks and command structures.
Recent discussions reveal a split between EU and US advisers regarding AstraZeneca's breast cancer drug, amid notable developments in other biotech areas.
Biogen and Denali's experimental treatment for Parkinson's disease has not achieved its trial objectives, while Merck's lung cancer therapy appears to offer potential benefits.
A recent CDC page on mpox has become a focal point of political debate, highlighting issues related to public health communication amid rising concerns about various health topics.
As the establishment of a federal office dedicated to men's health appears imminent, concerns grow over its potential fate under future administrations.
Genentech is seeking research to bolster its position against potential pharmaceutical reforms in Washington, aiming to influence policy discussions.
Recent findings reveal significant issues with the release of drugs from nanoparticle carriers, raising concerns for the future of precision medicine.
Scientists at Northwestern Medicine have introduced a novel method to study protein domain fluctuations, potentially advancing data-driven modeling in biology.
A targeted chemotherapy developed by Kelun-Biotech and licensed to Merck shows a 65% reduction in tumor progression risk for lung cancer patients in Phase 3 trials.
Shares in US cosmetics giant jump 11.5% in post-market trading as investors welcome end of talks
The Department of Justice has ordered an executive from Elevance to testify regarding allegations of fraudulent billing related to Medicare Advantage.
Eli Lilly's investigational drug, known as 'triple-G', has demonstrated significant effects on blood sugar and weight in a late-stage diabetes trial.
Recent research highlights leucine, a nutrient in protein-rich foods, as a key enhancer of mitochondrial function, potentially linking diet to energy production.
A new advisory from the Surgeon General's Office emphasizes the need for parents, schools, and government to restrict children's screen use, highlighting potential risks.
In a move to address leadership vacancies, Kennedy has appointed Stephanie Haridopolos, a family medicine physician and senior HHS adviser, as interim surgeon general.
A recent analysis sheds light on the ongoing effects of PEPFAR investments, indicating significant improvements in health indicators beyond HIV.